We are live on !
Find out more
Cliff Asness AQR Capital Management
AUM
$287B
Turnover
8.35%
1-Year Est. Return
42.33%
Cliff Asness is a co-founder of AQR Capital Management, a leading quantitative investment firm spanning equities, alternatives, and factor strategies. He is known for academic-informed research on value, momentum, and other systematic premia, as well as candid market commentary. Asness’s work bridges academic finance and large-scale institutional portfolio management.
This Fund
S&P 500
This Quarter Est. Return
+22.95%
1 Year Est. Return
+42.33%
3 Year Est. Return
+119.89%
5 Year Est. Return
+147.33%
10 Year Est. Return
+543.74%
AUM
$287B
AUM Growth
+$68.5B
(+31%)
Cap. Flow
+$37.5B
Cap. Flow % of AUM
Cap. Flow %
13.08%
Top 10 Holdings %
Top 10 Hldgs %
12.15%
Holding
3,986
New
247
Increased
2,455
Reduced
1,098
Closed
86
Avg Time Held
4.1
years
Top 10 Avg Time Held
3.3
years
Top 20 Avg Time Held
2.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.17B |
| 2 |
Apple
AAPL
|
+$849M |
| 3 |
Chevron
CVX
|
+$746M |
| 4 |
Synopsys
SNPS
|
+$643M |
| 5 |
Wells Fargo
WFC
|
+$633M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$517M |
| 2 |
Booking.com
BKNG
|
+$488M |
| 3 |
Walmart Inc
WMT
|
+$414M |
| 4 |
Sandisk
SNDK
|
+$355M |
| 5 |
Cigna
CI
|
+$325M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.5% |
| 2 | Financials | 14.38% |
| 3 | Industrials | 14.2% |
| 4 | Consumer Discretionary | 10.53% |
| 5 | Healthcare | 10.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1876
Inogen
INGN
$193M
| $6.05M | ﹤0.01% |
937,334
+510,216
| +119% | +$3.38M |
2022 Q3
15 quarters
|
|
1877
Liberty Global Class C
LBTYK
$2.59B
| $6.05M | ﹤0.01% |
552,099
+375,981
| +213% | +$4.35M |
2019 Q3
27 quarters
|
|
1878
Goldman Sachs Access Treasury 0-1 Year ETF
GBIL
$7.91B
| $6.04M | ﹤0.01% |
60,255
-11,668
| -16% | -$1.17M |
2025 Q4
2 quarters
|
|
1879
O-I Glass
OI
$813M
| $6.03M | ﹤0.01% |
625,777
+406,717
| +186% | +$3.83M |
2020 Q1
25 quarters
|
|
1880
BrightSpring Health Services
BTSG
$11.9B
| $6.02M | ﹤0.01% |
86,254
-7,147
| -8% | -$397K |
2025 Q1
5 quarters
|
|
1881
BlackRock US Equity Factor Rotation ETF
DYNF
$42.4B
| $6M | ﹤0.01% |
88,182
+10,163
| +13% | +$661K |
2024 Q3
7 quarters
|
|
1882
LandBridge Corporation
LB
$2.46B
| $5.99M | ﹤0.01% |
75,633
-2,170
| -3% | -$149K |
2025 Q3
3 quarters
|
|
1883
WisdomTree Trust WisdomTree US Quality Dividend Growth Fund
DGRW
$17.1B
| $5.99M | ﹤0.01% |
62,662
+19,487
| +45% | +$1.84M |
2024 Q4
6 quarters
|
|
1884
Uniti Group
UNIT
$1.25B
| $5.99M | ﹤0.01% |
522,294
+186,436
| +56% | +$2.12M |
2018 Q4
30 quarters
|
|
1885
Stride
LRN
$3.39B
| $5.96M | ﹤0.01% |
69,162
+42,814
| +162% | +$3.94M |
2022 Q1
17 quarters
|
|
1886
Treace Medical Concepts
TMCI
$329M
| $5.96M | ﹤0.01% |
1,497,673
+435,833
| +41% | +$1.2M |
2026 Q1
1 quarter
|
|
1887
Claritev Corp
CTEV
$407M
| $5.94M | ﹤0.01% |
174,011
+139,121
| +399% | +$3.41M |
2025 Q3
3 quarters
|
|
1888
WisdomTree
WT
$3.27B
| $5.93M | ﹤0.01% |
350,275
-104,703
| -23% | -$1.85M |
2023 Q2
12 quarters
|
|
1889
Omada Health Inc
OMDA
$1.2B
| $5.93M | ﹤0.01% |
270,233
-35,428
| -12% | -$566K |
2026 Q1
1 quarter
|
|
1890
Vir Biotechnology
VIR
$1.99B
| $5.92M | ﹤0.01% |
581,416
+15,407
| +3% | +$147K |
2022 Q1
17 quarters
|
|
1891
Caesars Entertainment
CZR
$5.94B
| $5.91M | ﹤0.01% |
197,664
-1,852,171
| -90% | -$52.2M |
2022 Q3
15 quarters
|
|
1892
DELISTED
Chart Industries
GTLS
| $5.89M | ﹤0.01% |
28,213
-34,355
| -55% | -$7.14M |
2024 Q4
6 quarters
|
|
1893
Sabre
SABR
$666M
| $5.89M | ﹤0.01% |
2,817,747
-337,541
| -11% | -$592K |
2023 Q3
11 quarters
|
|
1894
Puma Biotechnology
PBYI
$544M
| $5.88M | ﹤0.01% |
725,192
-75,002
| -9% | -$549K |
2024 Q4
6 quarters
|
|
1895
KKR Real Estate Finance Trust
KREF
$342M
| $5.88M | ﹤0.01% |
859,781
+792,407
| +1,176% | +$5.24M |
2025 Q2
4 quarters
|
|
1896
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
$11.3B
| $5.86M | ﹤0.01% |
38,004
+4,959
| +15% | +$778K |
2024 Q3
7 quarters
|
|
1897
Brady Corp
BRC
$3.89B
| $5.86M | ﹤0.01% |
63,956
-3,435
| -5% | -$286K |
2022 Q4
14 quarters
|
|
1898
iShares MSCI South Korea ETF
EWY
$23.7B
| $5.85M | ﹤0.01% |
28,977
+15,960
| +123% | +$2.82M |
2026 Q1
1 quarter
|
|
1899
Sphere Entertainment
SPHR
$4.06B
| $5.85M | ﹤0.01% |
33,805
-13,758
| -29% | -$1.92M |
2025 Q2
4 quarters
|
|
1900
Sprinklr
CXM
$1.58B
| $5.84M | ﹤0.01% |
1,132,513
+316,446
| +39% | +$1.68M |
2022 Q4
14 quarters
|
|
Similar funds
Cliff Asness's Q2 2026 Portfolio in Review
As of Q2 2026, Cliff Asness held 3,986 positions worth $287B, up 31% from $218B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Cliff Asness deployed $37.5B of net new capital in Q2 2026, opening 247 new positions and adding to 2,455 existing holdings. Its largest new stake was FedEx Freight: 1,024,555 shares worth $155M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 22% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Micron Technology, an estimated $517M trimmed.
- Cliff Asness's largest Q2 2026 buy was FedEx Freight: 1,024,555 shares worth $155M.
- Cliff Asness added most to NVIDIA in Q2 2026, an estimated $1.17B increase.
- Cliff Asness's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $517M.
- Cliff Asness fully exited Masimo in Q2 2026, selling an estimated $147M.
- Cliff Asness's ten largest holdings make up 12% of its $287B portfolio in Q2 2026.
- Cliff Asness opened 247 new positions and closed 86 in Q2 2026.
- Cliff Asness's portfolio value rose 31% quarter-over-quarter to $287B.
Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.